Name | TRPV3 antagonist 74a |
---|
Description | TRPV3 antagonist 74a is a potent and selective TRPV3 antagonist. TRPV3 antagonist 74a displays no significant activity against a panel of other ion channels. TRPV3 antagonist 74a can be used for the research of neuropathic pain[1][2]. |
---|---|
Related Catalog | |
Target |
TRPV3 |
In Vitro | TRPV3 antagonist 74a (100 μΜ; 2300 seconds; keratinocytes) largely attenuates SLIGRL or SLIGKV-induced Ca2+ responses[2]. |
In Vivo | TRPV3 antagonist 74a (150 μg; intradermal injection; 30 minutes) decreases the number of scratches significantly[2]. .TRPV3 antagonist 74a (10~100 mg/kg; p.o.) dose-dependently attenuates mechanical allodynia induced by von Frey hair stimulation to the ipsilateral (injured) hind paw. TRPV3 antagonist 74a exhibits anti-nociceptive activity in the reserpine model of central pain by increasing muscle pressure threshold[1]. Animal Model: WT mice Dosage: 150 μg Administration: Intradermal injection; 30 minutes Result: The number of scratches decreased significantly. |
References |
Molecular Formula | C17H17F3N2O2 |
---|---|
Molecular Weight | 338.32 |